SynCrest Launches CRDMO Service for Peptide-based Therapeutics

Otsuka Chemical and Yokogawa Electric to Launch SynCrest Inc., a Joint Venture Targeting the CRDMO Business for Middle-molecular Drugs

Donations to Support Relief Efforts Following Earthquakes in Turkey and Syria